Brian Casey[email protected]Nuclear MedicineMRI debunks 'liberation therapy' | PET/CT guides pediatric cancer biopsy | 8 ways to win turf battlesMarch 8, 2017Ob/GynECR 2017 wrap-up | Why don't more women get UFE? | Biomarkers for NASHMarch 6, 2017BreastECR 2017 stands tall as showcase for product launchesVIENNA - The European Congress of Radiology in recent years has come into its own as a showcase for new launches of medical imaging products. ECR 2017 was no exception, with a variety of new scanner debuts in MRI, CT, and other modalities.March 3, 2017MRINews from ECR 2017 | Creating a culture of safety | Breast MRI and mastectomyMarch 1, 2017MRISiemens to launch new 3T Vida MRI scanner at ECR 2017Siemens Healthineers plans to use ECR 2017 this week as the platform to launch Magnetom Vida, a new 3-tesla MRI scanner. Vida is the first system based on BioMatrix, a new Siemens technology that adapts scanning parameters to patient anatomy and physiology.February 28, 2017MRIMRI of implant patients | Mammo guidelines and screening | #MyRadGirlfriend and the EDFebruary 22, 2017MRICardiac implants may be safer in MRI than thoughtA new study published February 23 in the New England Journal of Medicine indicates that implantable cardiac devices may be safer in the MRI environment than previously thought. In more than 1,000 patients who received nonthoracic scans, researchers found no device or lead failures, even with devices that were not certified for use with MR imaging.February 22, 2017Digital X-RayPhilips launches new Azurion interventional platformIn what the company is calling its most significant new product launch in years, Philips Healthcare on Wednesday debuted Azurion, a new platform for image-guided therapy. The platform includes hardware and software improvements designed to enable clinicians to more efficiently perform complex interventional procedures.February 21, 2017MRIScreening breast MRI | Synthesized 2D DBT gets thumbs-up | Low-yield imagingFebruary 20, 2017BreastStudy gives thumbs-up to synthesized 2D DBT screeningA new study published February 21 in Radiology should put to rest any fears about the suitability of synthesized 2D digital breast tomosynthesis (DBT) for breast screening. Researchers who used the technology to screen more than 16,000 women found it had lower recall rates with no compromise in cancer detection.February 20, 2017Previous PagePage 74 of 140Next PageTop StoriesMolecular ImagingPET/CT metric improves outcome predictions in Pluvicto patientsThe inclusion of total tumor volume (TTV) produces prediction models with better discriminatory ability.Molecular ImagingNew recommendations issued on tau PET imagingCTSignificant incidental lung findings on LDCT tied to other cancersClinical NewsImaging exam interpretation times show sharp increaseSponsor ContentModernizing Radiotherapy Workflows
